View of COMPARATIVE STUDY OF CLINICAL SAFETY OUTCOME OF NEOADJUVANT INTRAVESICAL MITOMYCIN-C THERAPY IMMEDIATELY BEFORE TRANSURETHRAL RESECTION OF BLADDER TUMOR VS PERIOPERATIVE INTRAVESICAL MITOMYCIN-C IN PATIENTS WITH NONMUSCLE-INVASIVE BLADDER CANCER

Return to Article Details COMPARATIVE STUDY OF CLINICAL SAFETY OUTCOME OF NEOADJUVANT INTRAVESICAL MITOMYCIN-C THERAPY IMMEDIATELY BEFORE TRANSURETHRAL RESECTION OF BLADDER TUMOR VS PERIOPERATIVE INTRAVESICAL MITOMYCIN-C IN PATIENTS WITH NONMUSCLE-INVASIVE BLADDER CANCER Download Download PDF